Abstract |
|
Authors | Yoshitaka Narita |
Journal | Japanese journal of clinical oncology
(Jpn J Clin Oncol)
Vol. 43
Issue 6
Pg. 587-95
(Jun 2013)
ISSN: 1465-3621 [Electronic] England |
PMID | 23585688
(Publication Type: Journal Article, Review)
|
Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal, Humanized
- Bevacizumab
|
Topics |
- Angiogenesis Inhibitors
(adverse effects, therapeutic use)
- Antibodies, Monoclonal, Humanized
(adverse effects, therapeutic use)
- Bevacizumab
- Brain Neoplasms
(drug therapy, mortality, pathology, radiotherapy, secondary)
- Disease-Free Survival
- Glioblastoma
(drug therapy, mortality, pathology, radiotherapy)
- Humans
- Intracranial Hemorrhages
(chemically induced, etiology)
- Magnetic Resonance Imaging
- Meningioma
(drug therapy)
- Neoplasm Recurrence, Local
(drug therapy)
- Neurilemmoma
(drug therapy)
- Radiation Injuries
(drug therapy)
- Treatment Outcome
- Venous Thromboembolism
(chemically induced, etiology)
|